Medicare Enrolled
Dr. Mirwais Saifi, MD
Family Medicine · San Diego, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Saifi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Saifi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Saifi
Dr. Mirwais Saifi is a family medicine specialist in San Diego, CA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Saifi performed 2,691 Medicare services across 811 unique beneficiaries.
Between the years covered by Open Payments, Dr. Saifi received a total of $22,525 from 63 pharmaceutical and/or device companies across 725 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Saifi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 7% volume in CA
$22,525 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,691
Medicare services
Top 7% in CA for family medicine
811
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~168 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Home visit, established patient, high complexity A home visit for an established patient involving high-level medical decision making, lasting at least 60 minutes. |
1,362 | $106 | $277 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
665 | $70 | $125 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
92 | $0 | $4 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
78 | $1 | $17 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
77 | $12 | $40 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
75 | $1 | $11 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
58 | $98 | $165 |
| Home visit, new patient, moderate complexity A home visit for a new patient involving moderate medical decision making, lasting at least 60 minutes. |
51 | $107 | $285 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
51 | $33 | $35 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
37 | $59 | $60 |
| Home visit, established patient, moderate complexity A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service. |
26 | $80 | $270 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
25 | $55 | $124 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
23 | $9 | $15 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
18 | $85 | $150 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
16 | $138 | $175 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
14 | $226 | $325 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
12 | $12 | $65 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
11 | $152 | $225 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$22,525
Total received (2018-2024)
Avg $3,218/year across 7 years
Top 1% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
725
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,430 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$95 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,455
2023
$4,708
2022
$4,732
2021
$4,066
2020
$445
2019
$1,584
2018
$2,535
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$985
GlaxoSmithKline, LLC.
$522
ABBVIE INC.
$494
Bayer Healthcare Pharmaceuticals Inc.
$298
Lilly USA, LLC
$293
Janssen Pharmaceuticals, Inc
$250
Novartis Pharmaceuticals Corporation
$200
Boehringer Ingelheim Pharmaceuticals, Inc.
$192
Novo Nordisk Inc
$166
Actelion Pharmaceuticals US, Inc.
$153
Gilead Sciences, Inc.
$125
Axsome Therapeutics, Inc.
$113
Merck Sharp & Dohme LLC
$97
Daiichi Sankyo Inc.
$91
United Therapeutics Corporation
$87
PFIZER INC.
$64
Amgen Inc.
$45
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$41
Lundbeck LLC
$37
Otsuka America Pharmaceutical, Inc.
$37
Kowa Pharmaceuticals America, Inc.
$32
Vanda Pharmaceuticals Inc.
$31
E.R. Squibb & Sons, L.L.C.
$26
Seqirus USA Inc
$25
Neurelis, Inc.
$19
Vision Quest Industries Inc.
$15
IDORSIA PHARMACEUTICALS US INC
$15
Top 3 companies account for 44.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$2,935
AstraZeneca Pharmaceuticals LP
$2,878
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,011
AbbVie Inc.
$1,320
GlaxoSmithKline, LLC.
$1,300
ABBVIE INC.
$943
Lilly USA, LLC
$889
Novartis Pharmaceuticals Corporation
$863
Janssen Pharmaceuticals, Inc
$823
Avanir Pharmaceuticals, Inc.
$672
Biohaven Pharmaceuticals, Inc.
$547
Bayer HealthCare Pharmaceuticals Inc.
$498
PFIZER INC.
$421
Actelion Pharmaceuticals US, Inc.
$419
Daiichi Sankyo Inc.
$347
Amgen Inc.
$341
United Therapeutics Corporation
$302
Abbott Laboratories
$301
Bayer Healthcare Pharmaceuticals Inc.
$298
La Jolla Pharmaceutical Company
$285
SK Life Science, Inc.
$249
Merck Sharp & Dohme LLC
$238
Axsome Therapeutics, Inc.
$231
Boston Scientific Corporation
$208
ITI, Inc.
$207
Vanda Pharmaceuticals Inc.
$202
Biohaven Pharmaceutical Holding Company Ltd.
$186
Lundbeck LLC
$173
Merck Sharp & Dohme Corporation
$170
SANOFI-AVENTIS U.S. LLC
$164
CVRx, Inc.
$156
EISAI INC.
$154
Gilead Sciences, Inc.
$125
Chiesi USA, Inc.
$125
Allergan Inc.
$125
GENZYME CORPORATION
$124
Mallinckrodt LLC
$122
Lexicon Pharmaceuticals, Inc.
$120
Otsuka America Pharmaceutical, Inc.
$109
Esperion Therapeutics, Inc.
$109
Allergan, Inc.
$95
Takeda Pharmaceuticals U.S.A., Inc.
$84
Seqirus USA Inc
$80
Vision Quest Industries Inc.
$51
Ironwood Pharmaceuticals, Inc
$49
E.R. Squibb & Sons, L.L.C.
$43
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$41
Neurelis, Inc.
$37
Sumitomo Pharma America, Inc.
$34
Eisai Inc.
$33
Kowa Pharmaceuticals America, Inc.
$32
IDORSIA PHARMACEUTICALS US INC
$31
Intuity Medical Inc
$29
Nevro Corp.
$25
Alnylam Pharmaceuticals Inc.
$23
Alkermes, Inc.
$22
AbbVie, Inc.
$22
Collegium Pharmaceutical, Inc.
$22
Xeris Pharmaceuticals, Inc.
$19
Tactile Systems Technology Inc
$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$17
ARBOR PHARMACEUTICALS, INC.
$16
Teva Pharmaceuticals USA, Inc.
$16
Top 3 companies account for 34.7% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · AMVUTTRA · ANDEXXA · ANORO ELLIPTA · AREXVY · ARISTADA · AUSTEDO · AVYCAZ · Aimovig · Auvelity · BELSOMRA · BREZTRI · Barostim Neo System · Belbuca · CAPLYTA · CLEVIPREX · CREON · Creon · DALVANCE · DUPIXENT · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · FANAPT · FARXIGA · FASENRA · FLUCELVAX QUADRIVALENT · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · Flexitouch Plus · Fluad Quadrivalent · Flucelvax · GEMTESA · GIAPREZA · GVOKE PFS · HETLIOZ · Horizant · INJECTAFER · Inpefa · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · LYRICA · Linzess · MITRACLIP · MOUNJARO · NAVITOR · NEXLETOL · NEXLIZET · NORTHERA · NUCALA · NUEDEXTA · NURTEC ODT · OACTIVE ALIGN CUSTOM R · OFEV · OFIRMEV · ONZETRA Xsail · OPSUMIT · Otezla · Ozempic · PRADAXA · Pogo Automatic Blood Glucose Monitoring System · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · SYNJARDY · SYNTHROID · Saxenda · Senza · TEZSPIRE · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TYVASO · Tresiba · UBRELVY · UPTRAVI · VALTOCO · VERQUVO · VIBERZI · VIIBRYD · VRAYLAR · Veklury · Victoza · WATCHMAN Access System · WINREVAIR · Wegovy · XARELTO · XCOPRI · XIFAXAN · ZORYVE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for family medicine in CA.
Geographic Context
Family medicine physicians within 10 mi
1,322
Per 100K population
40.3
County median income
$102,285
Nearest hospital
GROSSMONT HOSPITAL
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Saifi is a clinical cardiology specialist, with above-average Medicare volume (top 7% in CA), with low-engagement industry engagement in the top 1% of CA peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Saifi experienced with home visit, established patient, high complexity?
Based on Medicare claims data, Dr. Saifi performed 1,362 home visit, established patient, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Saifi receive payments from pharmaceutical companies?
Yes. Dr. Saifi received a total of $22,525 from 63 companies across 725 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Saifi's costs compare to other family medicine physicians in San Diego?
Dr. Saifi's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Saifi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in San Diego
Browse family medicine physicians in San Diego ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in CA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in CA
Which CA family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology